NCT05198102View on ClinicalTrials.gov

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

July 19, 2022

Study Completion Date

July 19, 2022

Conditions
Prevention of COVID-19
Interventions
BIOLOGICAL

Recombinant novel coronavirus vaccine (CHO cells)

At 12 months after the basic immunization (window period ± 3 months), 1 dose of recombinant novel coronavirus vaccine (CHO cells) is vaccinated.

Trial Locations (1)

410005

Hunan Provincial Center for Disease Control and Prevention, Changsha

All Listed Sponsors
lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT05198102 - ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization | Biotech Hunter | Biotech Hunter